Finasteride Cost in New York 2026: Cash Pay, Insurance, Medicaid, and Compounded Options

What Does Finasteride Actually Cost in New York in 2026?

Generic finasteride 1 mg tablets average about $12 per month at New York retail pharmacies when a free discount card from GoodRx, RxSaver, or a similar aggregator is applied at checkout. Without any discount, the same supply may run $25 to $40 per month depending on the pharmacy chain. Brand-name Propecia carries a manufacturer list price near $85 per month, a figure most paying patients never actually pay because generic substitution is available and widely accepted by prescribers across New York.

The 5 mg tablet used for benign prostatic hyperplasia (BPH, sold as Proscar) runs slightly higher in absolute cost but lower on a per-milligram basis, and many cost-conscious patients prescribed the 5 mg dose split tablets under physician guidance. Splitting is common in clinical practice but should only be done when a prescriber explicitly approves it. The FDA finasteride labeling addresses both indications separately, and dose selection must match the approved indication. [1]

Price varies by borough and pharmacy network. A 90-day supply at Costco Pharmacy in Queens may cost under $25 cash-pay, while a small independent pharmacy in Manhattan might quote $55 for the same supply without a coupon code applied. Always price-check across at least three platforms before filling. The New York State Department of Health maintains a pharmacy locator that includes pricing transparency resources for state residents. [2]

Finasteride works by inhibiting 5-alpha-reductase type II, the enzyme that converts testosterone to dihydrotestosterone (DHT). Reducing scalp DHT by roughly 60 to 70 percent is the mechanism behind hair follicle preservation in androgenetic alopecia. [3] Kaufman et al. (J Am Acad Dermatol, 1998, N=1,553) demonstrated that finasteride 1 mg/day produced statistically significant increases in hair count at 12 and 24 months versus placebo (P<0.001), establishing the clinical rationale for long-term daily use that makes monthly cost a legitimate planning concern for patients. [4]

How New York Medicaid Covers Finasteride

New York Medicaid covers finasteride for both androgenetic alopecia and BPH, but requires prior authorization (PA) in both cases. Without an approved PA, the claim will be rejected at the pharmacy counter.

To obtain PA for AGA, a prescriber typically must document that the patient has a confirmed diagnosis, that the hair loss is clinically significant, and in some managed-care plans, that at least one formulary-preferred topical agent (usually minoxidil) has been tried first. For BPH, documentation of symptom severity scores, prostate volume measurement, or urological evaluation notes usually satisfies the PA requirement. New York Medicaid managed-care organizations (MCOs) each maintain their own PA forms, so the specific paperwork varies by plan. The New York State Medicaid program follows the federal CMS Medicaid drug coverage framework and state supplemental rebate agreements that influence which drugs are preferred. [5]

Once PA is approved, the patient cost-share under standard New York Medicaid is typically $0 to $3 per prescription fill, making finasteride effectively free for most Medicaid recipients who clear the PA hurdle. Essential Plan enrollees in New York face $0 copays for most generic medications under the plan's cost-sharing structure. [6]

Managed Medicaid plans in New York (Healthfirst, MetroPlus, Fidelis Care, Molina, etc.) each publish their own preferred drug lists. Calling the member services number on the back of the Medicaid card is the fastest way to confirm whether finasteride is on the preferred tier and what specific PA documents the plan requires.

A prescriber familiar with the NY Medicaid PA process can often submit documentation electronically through the eMedNY system. [7] Approval turnaround for straightforward BPH cases is typically two to five business days. AGA cases occasionally require a dermatologist note if a primary care prescriber's documentation is challenged.

Is Compounded Finasteride Legal in New York?

Compounded finasteride is legal in New York when prepared by a state-licensed 503A compounding pharmacy operating under New York State Board of Pharmacy (NYSBOP) rules and complying with USP Chapter standards. [8]

Section 503A of the federal Food, Drug, and Cosmetic Act governs traditional compounding pharmacies. Under 503A, a pharmacy may compound finasteride for an individual patient provided: a valid prescription exists, the compound is not essentially a copy of a commercially available product without a clinical rationale, and the pharmacy holds a current New York State pharmacy license. The NYSBOP can audit compounding practices and revoke licenses for non-compliance, so reputable 503A pharmacies maintain rigorous quality documentation. [9]

Compounded finasteride in New York commonly appears as:

• Oral capsules or troches at doses that differ from the commercial 1 mg or 5 mg tablets
• Topical solutions (often 0.1% or 0.25% finasteride in a carrier) for patients who want to avoid systemic absorption
• Combination formulations pairing finasteride with minoxidil in a single topical vehicle

The average cost for compounded finasteride through a licensed New York 503A pharmacy runs approximately $45 per month, well above the generic tablet cash price of $12 per month but sometimes justified by the non-standard dose, route, or combination not available commercially. Patients should confirm the compounding pharmacy's NYSBOP license status before purchasing. [10]

The FDA has not approved any compounded finasteride product, meaning efficacy and sterility data from the commercial approval do not automatically transfer to compounded versions. Patients choosing compounded formulations accept some additional uncertainty on potency and consistency. Clinical pharmacists at academic medical centers in New York generally recommend compounding only when a commercially available product is genuinely inadequate for the patient's clinical situation. [11]

Which Insurance Plans Cover Finasteride in New York?

Most commercial insurance plans active in New York cover generic finasteride for BPH without prior authorization or with a straightforward step-therapy requirement. Coverage for the AGA indication is less consistent and frequently classified as a cosmetic benefit exclusion.

BPH coverage. Empire BlueCross BlueShield, UnitedHealthcare, Aetna, and Cigna plans sold in New York generally place generic finasteride 5 mg on Tier 1 or Tier 2 of the formulary for the BPH indication, resulting in copays of $5 to $20 per 30-day fill. [12] Some plans require that the patient try an alpha-blocker (tamsulosin, doxazosin) before authorizing finasteride for BPH, a step-therapy protocol aligned with AUA guidelines recommending combination therapy discussion in appropriate patients. [13]

AGA coverage. Finasteride 1 mg for hair loss is excluded from coverage by a significant proportion of commercial plans in New York because many carrier medical policies categorize male-pattern hair loss as a cosmetic condition. Patients should request a formal coverage determination letter rather than relying on a verbal denial, because some plans will cover finasteride under a physician's medical-necessity letter, particularly when hair loss is associated with a documented medical cause such as alopecia areata or post-chemotherapy recovery. [14]

Marketplace plans. Qualified Health Plans (QHPs) sold through NY State of Health, the state's official health plan marketplace, must cover essential health benefits. Prescription drug benefits under QHPs vary by insurer, and finasteride for AGA is commonly excluded. BPH-indication finasteride fares better and is often covered on QHP formularies. [15]

Medicare Part D. Medicare Part D plans available to New York beneficiaries cover finasteride 5 mg for BPH, with coverage for 1 mg for AGA varying by plan. The Medicare Plan Finder tool at cms.gov allows comparison of Part D formularies by zip code. [16]

The HealthRX NY Insurance Navigator Framework: When a New York insurer denies finasteride for AGA, the patient's appeals pathway has three steps. Step one: request the internal appeal in writing within 60 days of the denial, attaching the prescriber's letter of medical necessity. Step two: if the internal appeal fails, file an external appeal with the NY Department of Financial Services, which is required by New York Insurance Law Section 4910 to assign an independent reviewer within 45 business days for standard appeals. Step three: if the external appeal confirms the exclusion, pursue the cash-pay generic ($12/month) or confirm Medicaid eligibility. Most AGA patients who clear steps one and two with strong prescriber documentation obtain coverage at the Tier 2 generic rate.

How to Get Finasteride via Telehealth in New York

Telehealth prescribing of finasteride is fully permitted in New York for both AGA and BPH. New York's telehealth parity law (Public Health Law Section 2999-o) requires commercial insurers to cover telehealth services on the same basis as in-person services. [17] A licensed New York prescriber (physician, nurse practitioner, or physician assistant) may conduct a synchronous or asynchronous telehealth visit, evaluate the patient, and issue a finasteride prescription that any New York-licensed pharmacy can fill.

Platforms offering telehealth hair-loss consultations to New York residents typically charge a one-time consultation fee of $25 to $75, then route the prescription to the patient's chosen pharmacy. Some platforms bundle the consultation with a 90-day generic finasteride supply for a flat fee of $30 to $60, which can undercut brick-and-mortar pharmacy cash prices when the consultation fee is effectively subsidized by prescription volume. Patients should verify that the prescribing clinician holds a valid New York State license before completing the consultation, as out-of-state prescribers cannot legally prescribe controlled or non-controlled substances to New York patients without a NY license. [18]

The American Academy of Dermatology's position on teledermatology acknowledges that photographic or video assessment of androgenetic alopecia is clinically adequate for prescribing finasteride in most cases, given that the diagnosis is typically established by visual inspection and patient history. [19] Patients with atypical hair-loss patterns (scarring alopecia, patchy loss, rapid onset) should seek in-person evaluation before starting finasteride, as these presentations may require biopsy or laboratory workup not achievable via telehealth. [20]

Savings Programs and Discount Strategies for New York Patients

Several concrete tools reduce out-of-pocket finasteride costs for New York residents.

GoodRx and RxSaver coupons. Free coupon codes from GoodRx, RxSaver, and Blink Health consistently price generic finasteride 1 mg (30 tablets) between $8 and $16 at major New York pharmacy chains including CVS, Walgreens, Rite Aid, and Duane Reade. These discount cards cannot be combined with insurance; the patient must choose one or the other at the counter. The lower cash-pay price sometimes beats the insurance copay for patients on high-deductible health plans. [21]

Manufacturer savings programs. Merck previously offered a Propecia savings card for brand-name finasteride, though savings card programs for brand-name drugs fluctuate year to year. As of 2026, generic finasteride is so inexpensive that brand savings cards offer limited marginal value for most New York patients. Patients interested in brand savings should check Merck's official patient assistance page directly. [22]

Patient Assistance Programs (PAPs). Merck's patient assistance program (MAP) provides free or reduced-cost Propecia to qualifying uninsured or underinsured patients who meet income criteria. Income thresholds are updated annually. Patients should apply through the prescribing physician's office or directly via Merck's program portal. [23]

New York's 340B Program access. Federally Qualified Health Centers (FQHCs) and other 340B-covered entities in New York can dispense drugs at 340B ceiling prices, which for generic finasteride may result in near-zero cost for eligible low-income patients. Patients must receive care at a 340B-participating site to access these prices. New York has one of the largest 340B pharmacy networks in the country. [24]

90-day supply fills. Filling a 90-day supply instead of monthly reduces per-unit cost at most pharmacies by 10 to 20 percent and reduces dispensing fees. Most New York Medicaid and commercial plans permit 90-day fills for maintenance medications like finasteride. [25]

Clinical Considerations That Affect Long-Term Cost Planning

Finasteride for AGA requires continuous daily use to maintain benefit. Hair counts gained during treatment are lost within 9 to 12 months of stopping the medication, according to the 5-year follow-up data from the Phase III finasteride studies included in the original FDA approval dossier. [26] This means cost planning must account for indefinite monthly expenditure, not a finite treatment course.

The most comprehensive long-term efficacy data come from the Kaufman et al. study published in the Journal of the American Academy of Dermatology (1998), which followed 1,553 men for two years and showed that 83 percent of finasteride-treated men maintained or increased hair count versus only 28 percent in the placebo group. [4] The effect size narrows slightly over longer durations but remains clinically meaningful through five years of treatment. [27]

For BPH patients, the Medical Therapy of Prostatic Symptoms (MTOPS) trial (N=3,047) demonstrated that finasteride reduced the relative risk of overall BPH progression by 34 percent compared with placebo over 4.5 years, with larger benefit in men with prostate volumes greater than 25 mL. [28] These patients are more likely to have their prescription covered by insurance under the BPH indication, reducing cost burden substantially compared with AGA patients paying cash.

Adverse effects with cost implications: approximately 3.8 percent of men in Phase III trials reported sexual side effects (decreased libido, ejaculatory dysfunction, or erectile dysfunction) that resolved after stopping the drug in most cases. [29] A small subset of patients reports persistent sexual side effects after discontinuation, a condition sometimes labeled post-finasteride syndrome, though the FDA label documents the reversibility rate as high in trial populations. Patients who discontinue due to side effects incur the cost of the drug for the period used without realizing the hair-growth benefit, a financial and clinical consideration worth discussing with the prescribing clinician before starting. [30]

Laboratory monitoring is not routinely required for AGA dosing (1 mg). BPH patients on finasteride should have PSA levels interpreted with the understanding that finasteride reduces PSA by approximately 50 percent after 6 months of use; a PSA level that appears normal may mask a clinically significant PSA elevation if the correction factor is not applied. The AUA guideline recommends doubling the PSA value in patients on finasteride to estimate the true PSA for screening purposes. [31] This monitoring consideration does not add significant direct cost but is worth noting when planning total care expenditure.

Comparing Your Four Main Pathways to Finasteride in New York

New York patients realistically have four options for obtaining and paying for finasteride.

Option 1: Cash-pay generic at retail pharmacy. Approximately $12 per month with a discount coupon. No insurance required, no PA process, available same day at most pharmacies. Best for uninsured patients or those on high-deductible plans whose deductible has not been met.

Option 2: Insurance (commercial or Medicare Part D) for BPH. Copay of $5 to $20 per month once on formulary. Requires the BPH diagnosis code on the prescription. May require step-therapy with an alpha-blocker first. Best for patients with BPH who have commercial or Medicare coverage.

Option 3: New York Medicaid with PA. Effective cost of $0 to $3 per fill for eligible enrollees. Requires prior authorization and may take 2 to 10 business days for approval. Best for income-qualifying patients.

Option 4: Compounded finasteride via 503A pharmacy. Approximately $45 per month for topical or non-standard oral formulations. Adds flexibility in dose and delivery but costs more than generic tablets and is not FDA-approved. Best for patients who have a documented clinical reason the commercial product is inadequate, such as tablet intolerance, a dose between 1 mg and 5 mg, or a combination topical formulation. [32]

For most New York men seeking finasteride for AGA who do not qualify for Medicaid, Option 1 at roughly $144 per year is the most cost-efficient starting point. Patients with BPH should run a formal formulary check before defaulting to cash-pay, because the insurance route may be cheaper from the first fill.